ENTO

Entero Therapeutics
ENTO

Overview Fund Trends Analyst Outlook Journalist POV

3 hedge funds and large institutions have $18.4K invested in Entero Therapeutics in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
3
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$9.57K
2
+$6.1K
3
+$13

Top Sellers

1
-$23.7K
2
-$15K
3
-$12.3K
4
OAC
OMERS Administration Corp
Ontario, Canada
-$8.64K
5
HF
HRT Financial
New York
-$5K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$11.9K
2
$6.46K
3
$25
4
$4
5
$4
6
–
7
–
8
–
9
–
10
–
11
–
12
–
13
–
14
–
15
–